Health - Friday, June 19, 2026

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Eating five servings of fruits and vegetables may not be enough if you're missing foods rich in flavanols, a group of compounds linked to better heart health. Researchers found that choices like blackberries, plums, apples, broad beans, cherries, and green tea can dramatically increase flavanol intake.

A newly identified molecule called OLE helped restore the brain’s immune cells to a more protective state in Alzheimer’s models. The treatment reduced toxic plaque buildup and improved memory, raising hopes for a new therapeutic approach.

Following the pandemic, the federal government is spending $150 million on new technology to ensure clean indoor air. Here’s what scientists are pursuing.

Shrinking fertility should mean less strain on doctors. But nearly half of U.S. counties lack a practicing obstetrician or gynecologist.

The co-founders of Darwin Health write that the real work for making dramatic gains against pancreatic cancers is just beginning.

Tennessee pharmacies are selling potent versions of the antiparasitic drug ivermectin, led by an anti-vaccine doctor who’s taken "bucketloads."

Disability researchers across the country worry about their jobs, and the future of their institutions, as a delay in issuing federal grants drags on.

A new biomaterial made from jackfruit latex, pomegranate peel, and simvastatin could transform the treatment of severe gum disease. Early tests suggest it not only combats infection and inflammation but may also help rebuild lost bone and tissue around teeth.

Scientists may have uncovered a hidden trigger behind Alzheimer’s disease. Instead of plaques being the root cause, amyloid beta appears to interfere with tau, a protein that helps keep neurons functioning properly. This disruption could set off the damage that eventually leads to the disease’s most recognizable brain changes.